Self-reported non-severe hypoglycaemic events in Europe

Diabetic Medicine

Volumn 31, Issue 1, 2014, Pages 92-101

  Ostenson C G ^a   Geelhoed Duijvestijn, P ^b   Lahtela, J ^c   Weitgasser, R ^d,e   Markert Jensen, M ^f   Pedersen Bjergaard, U ^g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f NOVO NORDISK A S   (Denmark)

^g Department of Cardiology and Endocrinology   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LONG ACTING INSULIN; SHORT ACTING INSULIN;

ADOLESCENT; ADULT; AGE; ARTICLE; AWARENESS; BODY MASS; DEMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; EUROPE; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON SEVERE HYPOGLYCEMIA; PRACTICE GUIDELINE; QUESTIONNAIRE; SELF REPORT; TREATMENT DURATION;

ADULT; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; QUESTIONNAIRES; SELF CARE; SELF REPORT; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84890165658     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12261     Document Type: Article

References (25)

1. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140-1147.
2. European Medicines Agency Committee for Medical Products for Human Use (CHMP). Guidelines on clinical investigation of medical products in the treatment or prevention of diabetes mellitus. European Medicines Agency, 2012. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500129256&mid=WC0b01ac058009a3dc Last accessed 5 July 2013.
3. American Diabetes Association Workgroup on Hypoglycemia. Defining and Reporting Hypoglycemia in Diabetes. Diabetes Care 2005; 28: 1245-1249.
4. Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005; 21: 1477-1483.
5. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749-755.
6. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991; 8: 217-222.
7. Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011; 14: 665-671.
8. Lundkvist J, Berne C, Bolinder B, Jonsson L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ 2005; 6: 197-202.
9. Wild D, von MR, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns 2007; 68: 10-15.
10. Leiter LA, Yale JF, Chiasson JL, Harris S, Kleinstiver P, Sauriol L. Assessment of the Impact of Fear of Hypoglycemic Episodes on Glycemic and Hypoglycemia Management. Can J Diabetes 2005; 29: 1-7.
11. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centred approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-1596.
12. World ESOMAR Research. ICC/ESOMAR International Code on Market and Social Research 2012. International Chamber of Commerce (ICC), 2007. Available at: http://www.esomar.org/uploads/public/knowledge-and-standards/codes-and-guidelines/ICCESOMAR_Code_English_.pdf Last accessed 5 July 2013.
13. European Pharmaceutical Market Research Association. Code of Conduct 1997. Available at http://www.ephmra.org/professional-standards/mr-code-of-conduct.aspx Last accessed 5 July 2013.
14. Brod M, Pohlman B, Wolden M, Christensen T. Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being. Qual Life Res [ahead of print] 2012.
15. Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003; 19: 232-240.
16. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV, et al. Severe hypoglycemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004; 20: 479-486.
17. Kristensen PL, Hansen LS, Jespersen MJ, Pedersen-Bjergaard U, Beck-Nielsen H, Christiansen JS, et al. Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract 2012; 96: 17-23.
18. Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med 2006; 23: 750-756.
19. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995; 18: 517-522.
20. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697-703.
21. Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B. Classification of hypoglycemia awareness in people with type 1 diabetes in clinical practice. J Diabetes Complications 2010; 24: 392-397.
22. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997; 46: 271-286.
23. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
24. Internet World Stats. Internet Penetration Rates. Usage and population statistics. Available at: http://www.internetworldstats.com/europa2.htm. Last accessed 5 July 2013.
25. Heller S. Hypoglycaemia in diabetes. Medicine 2010; 38: 671-675.